Insider Transactions in Q4 2020 at Phreesia, Inc. (PHR)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 24
2020
|
Edward L Cahill Director |
SELL
Open market or private sale
|
Direct |
24,370
-25.63%
|
$1,389,090
$57.22 P/Share
|
Dec 17
2020
|
Cheryl Pegus |
SELL
Open market or private sale
|
Direct |
8,415
-33.41%
|
$471,240
$56.15 P/Share
|
Dec 16
2020
|
Cheryl Pegus |
SELL
Open market or private sale
|
Direct |
22,732
-47.44%
|
$1,250,260
$55.83 P/Share
|
Dec 16
2020
|
Cheryl Pegus |
BUY
Exercise of conversion of derivative security
|
Direct |
20,764
+30.23%
|
$228,404
$11.89 P/Share
|
Oct 23
2020
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,669
-5.12%
|
$329,422
$38.21 P/Share
|
Oct 23
2020
|
Thomas Altier Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,669
+4.87%
|
$0
$0.84 P/Share
|
Oct 22
2020
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
86,237
-34.95%
|
$3,190,769
$37.65 P/Share
|
Oct 22
2020
|
Thomas Altier Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
86,237
+25.9%
|
$0
$0.84 P/Share
|
Oct 21
2020
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
10,834
-17.56%
|
$379,190
$35.0 P/Share
|
Oct 21
2020
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
9,281
+13.07%
|
$18,562
$2.03 P/Share
|
Oct 12
2020
|
Thomas Altier Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,779
-4.05%
|
$216,928
$32.13 P/Share
|
Oct 12
2020
|
Thomas Altier Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,779
+3.89%
|
-
|
Oct 01
2020
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
14,774
-2.11%
|
$443,220
$30.93 P/Share
|
Oct 01
2020
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
4,477
-1.69%
|
$138,787
$31.38 P/Share
|
Oct 01
2020
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
1,377
+1.03%
|
$5,508
$4.71 P/Share
|